125 related articles for article (PubMed ID: 12543468)
1. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.
Freedland CS; Whitlow CT; Smith HR; Porrino LJ
Brain Res; 2003 Feb; 962(1-2):169-79. PubMed ID: 12543468
[TBL] [Abstract][Full Text] [Related]
2. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding.
Freedland CS; Poston JS; Porrino LJ
Pharmacol Biochem Behav; 2000 Oct; 67(2):265-70. PubMed ID: 11124390
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
4. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
[TBL] [Abstract][Full Text] [Related]
5. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
Mansbach RS; Rovetti CC; Winston EN; Lowe JA
Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
[TBL] [Abstract][Full Text] [Related]
7. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
Pério A; Barnouin MC; Poncelet M; Soubrié P
Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
[TBL] [Abstract][Full Text] [Related]
8. Effects of SR141716A on ethanol and sucrose self-administration.
Freedland CS; Sharpe AL; Samson HH; Porrino LJ
Alcohol Clin Exp Res; 2001 Feb; 25(2):277-82. PubMed ID: 11236843
[TBL] [Abstract][Full Text] [Related]
9. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.
De Vry J; Schreiber R; Eckel G; Jentzsch KR
Eur J Pharmacol; 2004 Jan; 483(1):55-63. PubMed ID: 14709326
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
[TBL] [Abstract][Full Text] [Related]
12. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).
Ward SJ; Dykstra LA
Behav Pharmacol; 2005 Sep; 16(5-6):381-8. PubMed ID: 16148442
[TBL] [Abstract][Full Text] [Related]
13. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
14. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.
Tsou K; Patrick SL; Walker JM
Eur J Pharmacol; 1995 Jul; 280(3):R13-5. PubMed ID: 8566091
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.
Thornton-Jones ZD; Vickers SP; Clifton PG
Psychopharmacology (Berl); 2005 May; 179(2):452-60. PubMed ID: 15821957
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.
Ward SJ; Lefever TW; Rawls SM; Whiteside GT; Walker EA
Psychopharmacology (Berl); 2009 Sep; 206(1):155-65. PubMed ID: 19575185
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments.
Rubino T; Viganò D; Zagato E; Sala M; Parolaro D
Synapse; 2000 Jan; 35(1):8-14. PubMed ID: 10579803
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.
Rinaldi-Carmona M; Barth F; Héaulme M; Alonso R; Shire D; Congy C; Soubrié P; Brelière JC; Le Fur G
Life Sci; 1995; 56(23-24):1941-7. PubMed ID: 7776817
[TBL] [Abstract][Full Text] [Related]
19. Effect of cannabinoid CB1 receptor antagonist SR141716A and CB1 receptor knockout on cue-induced reinstatement of Ensure and corn-oil seeking in mice.
Ward SJ; Walker EA; Dykstra LA
Neuropsychopharmacology; 2007 Dec; 32(12):2592-600. PubMed ID: 17392737
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.
Beardsley PM; Martin BR
Eur J Pharmacol; 2000 Jan; 387(1):47-53. PubMed ID: 10633159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
